Featured Stories
Country in Focus: Serbia
The total value of the pharmaceutical market in Serbia is € 833 million and it is estimated that it will grow by 6.7% from 2019 to 2021.
Read More
The 2020 International Medis Awards for Medical Research finalists are announced!
The 19 finalists were selected among as many as 222 nominees from 9 different medical fields.
Read More
#MedSafetyWeek – Every Report Counts and Can Help Others in the Future
Medis regularly encourages its employees to provide the necessary information from the market to ensure the best treatment options for our patients.
Read More
First-Hand Experience with Imunoglukan – Story of Nadja
For Nadja Ott, a pharmacist and Brand Manager, this period at Medis is very stressful, but at the same time, it is also exciting.
Read More
We Maintain the Best Balance Between Development and Risk
Interview with Erna Slana, Managing Director of the Finance and Accounting Division at Medis.
Read More
Medis Proudly Announces a New Partnership with Biocodex Nordics
Exclusive distribution agreement for Medis’ latest development Ladiva, which will be commercialized by Biocodex Nordics in Finland, represents a new important...
Read More